Heparin – An old drug with multiple potential targets in Covid‐19 therapy

To the Editor, A prominent clinical feature of severe Covid‐19 infection is respiratory failure associated with pulmonary coagulopathy. Recent reports published in the Journal of Thrombosis and Haemostasis show that treatment with low molecular weight heparin (LMWH) decreases mortality in critically ill patients with sepsis‐induced hypercoagulation, and thus argue for prophylactic administration of the anticoagulant.1.Lillicrap D. Disseminated...